Alexander Colevas
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Member, Stanford Cancer Institute
- Associate Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
Key Documents
Contact Information
-
Clinical Offices
Stanford Cancer Center 875 Blake Wilbur Drive Room 2328, MC 5826 Stanford, CA 94305 Tel Work (650) 724-9707 Fax (650) 498-5800
- Academic Offices
Personal Information Email Tel (650) 724-9707Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Head and Neck Cancer
- Medical Oncology
- Oncology (Cancer)
- developmental therapeutics
- investigational new drugs
- Adverse event( toxicity) evaluation and reporting
Professional Education
| Board Certification: | Medical Oncology, American Board of Internal Medicine (1995) |
| Fellowship: | Dana-Farber Cancer Institute MA (1995) |
| Medical Education: | Johns Hopkins School of Medicine MD (1989) |
| B. A.: | Columbia, Chemistry (1985) |
| M.D.: | Johns Hopkins, Medicine (1989) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Multi- modality treatment of Head and Neck Cancer
Phase 1 clinical trials
Clinical Trials
- Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
- Recruiting A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
- Not Recruiting Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
- Not Recruiting Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies
- Recruiting Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Publications
- Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. Cancer Chemother Pharmacol. 2013; (1): 193-202
- Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013; (7): 1349-56
- Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas. Laryngoscope. 2013
- Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity. Head Neck. 2013
- Stereotactic radiosurgery for retreatment of gross perineural invasion in recurrent cutaneous squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2013; (3): 293-8
- A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261. Gynecol Oncol. 2012; (1): 55-62
Help
Trial Administration